GE HEALTHCARE TECHNOLOGY (GEHC) Stock Price & Overview
NASDAQ:GEHC • US36266G1076
Current stock price
The current stock price of GEHC is 71.38 USD. Today GEHC is down by -1.22%. In the past month the price increased by 0.59%. In the past year, price increased by 4.33%.
GEHC Key Statistics
- Market Cap
- 32.57B
- P/E
- 15.59
- Fwd P/E
- 13.81
- EPS (TTM)
- 4.58
- Dividend Yield
- 0.19%
GEHC Stock Performance
GEHC Stock Chart
GEHC Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to GEHC. When comparing the yearly performance of all stocks, GEHC is a bad performer in the overall market: 74.08% of all stocks are doing better.
GEHC Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GEHC. GEHC scores excellent on profitability, but there are some minor concerns on its financial health.
GEHC Earnings
On February 4, 2026 GEHC reported an EPS of 1.44 and a revenue of 5.70B. The company beat EPS expectations (0.96% surprise) and missed revenue expectations (-0.44% surprise).
GEHC Forecast & Estimates
28 analysts have analysed GEHC and the average price target is 93.97 USD. This implies a price increase of 31.65% is expected in the next year compared to the current price of 71.38.
For the next year, analysts expect an EPS growth of 12.83% and a revenue growth 5.54% for GEHC
GEHC Groups
Sector & Classification
GEHC Financial Highlights
Over the last trailing twelve months GEHC reported a non-GAAP Earnings per Share(EPS) of 4.58. The EPS increased by 2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.11% | ||
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| Debt/Equity | 0.92 |
GEHC Ownership
GEHC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 14.59 | 161.117B | ||
| ISRG | INTUITIVE SURGICAL INC | 41.46 | 160.285B | ||
| SYK | STRYKER CORP | 21.78 | 125.349B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.6 | 88.457B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.06 | 45.956B | ||
| IDXX | IDEXX LABORATORIES INC | 39.06 | 45.191B | ||
| BDX | BECTON DICKINSON AND CO | 11.4 | 44.616B | ||
| RMD | RESMED INC | 18.08 | 32.227B | ||
| DXCM | DEXCOM INC | 24.93 | 24.092B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 17.942B | ||
| PODD | INSULET CORP | 29.86 | 13.321B | ||
| PEN | PENUMBRA INC | 65.18 | 12.858B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GEHC
Company Profile
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Company Info
IPO: 2022-12-15
GE HEALTHCARE TECHNOLOGY
500 West Monroe Street
Chicago ILLINOIS US
Employees: 54000
Phone: 18337351139
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
What does GEHC do?
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
What is the current price of GEHC stock?
The current stock price of GEHC is 71.38 USD. The price decreased by -1.22% in the last trading session.
What is the dividend status of GE HEALTHCARE TECHNOLOGY?
GE HEALTHCARE TECHNOLOGY (GEHC) has a dividend yield of 0.19%. The yearly dividend amount is currently 0.14.
What is the ChartMill rating of GE HEALTHCARE TECHNOLOGY stock?
GEHC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the PE ratio for GEHC stock?
The PE ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 15.59. This is based on the reported non-GAAP earnings per share of 4.58 and the current share price of 71.38 USD.
Who owns GE HEALTHCARE TECHNOLOGY?
You can find the ownership structure of GE HEALTHCARE TECHNOLOGY (GEHC) on the Ownership tab.
What is the Short Interest ratio of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The outstanding short interest for GE HEALTHCARE TECHNOLOGY (GEHC) is 2.72% of its float.